Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Covid-19 immunization: Total 0.18 percent adverse events reported on Tuesday, says Centre

Farhat Nasim20 Jan 2021 9:15 AM IST

New Delhi: Of the total people vaccinated against COVID-19 so far, the government on Tuesday said 0.18 percent were adverse events following...

India rolls out Mega Covid-19 vaccination drive

Farhat Nasim18 Jan 2021 10:00 AM IST

New Delhi: Paying tribute to healthcare workers, doctors, nurses, and scientists who were at the forefront of the fight against the pandemic, Prime...

NPPA brings Remoglifozin, Metformin combination under price control, pulls up Mankind, Intas Pharma for unapproved launch

Farhat Nasim15 Jan 2021 7:06 PM IST

New Delhi: In its recent most attempt to bring drugs under price control, NPPA has now set the maximum price for the FDC of Remoglifozin Etabonate and...

Dapagliflozin going off-patent- NPPA brings Dapagliflozin, Metformin Combination under price control

Farhat Nasim14 Jan 2021 5:15 PM IST

New Delhi: With the popular antidiabetic drug, Dapagliflozin going off-patent, the apex drug price regulator, National Pharmaceutical Pricing...

Dr Alexander Thomas takes charge as National President of AHPI

Farhat Nasim10 Jan 2021 9:15 AM IST

New Delhi: Eminent Dr Alexander Thomas has been re-elected as the National President of Association of Healthcare Providers India (AHPI) for the years...

Consumer Forum penalizes patient for false allegations of overcharging against cancer surgeon, path lab

Farhat Nasim8 Jan 2021 4:41 PM IST

Surat: Noting that the cancer patient had taken advantage of the doctor's humanity and levied false allegations of overcharging against a cancer...

Rs 278 Cr Indemnity Claim, Inflated GMV, Board Ouster: Inside the Medikabazaar Controversy

AIDAN slams approval of Covaxin, expresses alarm over lack of efficacy, trial data

Farhat Nasim5 Jan 2021 4:42 PM IST

New Delhi: Slamming the recent approval of Covid-19 vaccine, Covaxin, developed by Bharat Biotech in association with the Indian Council of...

CDSCO panel rejects Emcure Voglibose, Vildagliptin FDC citing dosage schedule incompatibility between ingredients

Farhat Nasim25 Dec 2020 1:18 PM IST

New Delhi: Citing dosage schedule incompatibility between the ingredients, the Subject Expert Committee (SEC) functional under the Central Drugs...

Semaglutide to be sold only on prescription of Endocrinologist, PG Medicine in India: CDSCO Committee

Farhat Nasim22 Dec 2020 4:58 PM IST

New Delhi: In a major development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has...

Cipla associate Avenue Therapeutics gets regulatory update for intravenous tramadol

Farhat Nasim18 Dec 2020 6:23 PM IST

Cipla said Avenue had requested this Type A meeting to address a CRL it received from the US health regulator regarding the New Drug Application (NDA)...

Raid: Rs 4 crore seized from pharma unit in Chandigarh

Farhat Nasim16 Dec 2020 5:54 PM IST

Chandigarh: A pharmaceutical firm, Nectar Lifesciences was recently raided by a team of the Income Tax Department, wherein, Rs 4 crore was seized from...

Insider Trading: Divis Labs individual slapped Rs 11 lakh fine, banned from securities market by SEBI

Farhat Nasim15 Dec 2020 6:13 PM IST

The watchdog had conducted an investigation into suspected insider trading activities of certain entities in the shares of Divi's Laboratories during...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok